Atezolizumab
A PD-L1 checkpoint inhibitor that blocks the interaction between PD-L1 on tumor cells and PD-1 on immune cells, releasing the brakes on the immune system so it can recognize and destroy cancer. It is approved for various cancers including bladder and certain types of lung and breast cancer.
ด้านการรักษา
หมวดหมู่ยา
กลไกการออกฤทธิ์
Fully human anti-PD-L1 IgG1 monoclonal antibody blocking PD-L1 interaction with PD-1 and B7.1.
Pharmacokinetics (PK)
Pharmacodynamics (PD)
Fully human anti-PD-L1 IgG1 monoclonal antibody blocking PD-L1 interaction with PD-1 and B7.1.
HBD / HBA
- / -
No targets recorded
Target interaction data is not yet available for this drug.
No interactions recorded
Drug interaction data is not yet available for this compound.
No side effects recorded
Side effect data is not yet available for this drug.
คำถามที่พบบ่อย
A PD-L1 checkpoint inhibitor that blocks the interaction between PD-L1 on tumor cells and PD-1 on immune cells, releasing the brakes on the immune system so it can recognize and destroy cancer. It is approved for various cancers including bladder and certain types of lung and breast cancer.
Fully human anti-PD-L1 IgG1 monoclonal antibody blocking PD-L1 interaction with PD-1 and B7.1.
Key pharmacokinetic parameters for Atezolizumab: Half-life: 27 days.
Yes, Atezolizumab is an approved drug. It has reached clinical phase 4. It is classified as a Antibody.
Related Drugs
References & Data Sources
- ChEMBL — European Bioinformatics Institute (EBI). CHEMBL3707227. Open-access bioactivity database.
Data aggregated from publicly available pharmacological databases. Last updated 2026-02-27.
ข้อจำกัดความรับผิดชอบทางการแพทย์
This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.
Embed This Widget
Add the script tag and a data attribute to embed this widget.
<script src="https://cdn.jsdelivr.net/npm/drugfyi-embed@1/dist/embed.min.js" defer></script>
<div data-drugfyi="drug" data-slug="atezolizumab"></div>Embed via iframe for maximum compatibility.
<iframe src="https://drugfyi.com/iframe/drug/atezolizumab/" width="420" height="400" frameborder="0" style="border:0;border-radius:10px;max-width:100%" loading="lazy"></iframe>Paste this URL in WordPress, Medium, or any oEmbed-compatible platform.
https://drugfyi.com/drug/atezolizumab/Add a dynamic SVG badge to your README or docs.
[](https://drugfyi.com/drug/atezolizumab/)Use the native HTML custom element.
<script src="https://cdn.jsdelivr.net/npm/drugfyi-embed@1/dist/embed.min.js" defer></script>
<drugfyi-drug slug="atezolizumab"></drugfyi-drug>